Effect of erectile dysfunction following prostate cancer treatment
Art & Science Previous     Next

Effect of erectile dysfunction following prostate cancer treatment

Robert McConkey Nurse, Urology Department, University College Hospital Galway, Galway, Ireland

Prostate cancer is the most prevalent non-cutaneous cancer in men worldwide. As a result of increased survival rates, men and their partners are living longer with the sexual sequelae of active treatments for prostate cancer, including surgery, radiotherapy and hormone therapy. The effect of erectile dysfunction on the patient and his partner is complex; many men experience psychosocial effects influenced by their hegemonic masculine beliefs. Some men experience difficulties in addressing their needs and require support while they attempt to reframe their beliefs about masculinity. The PLISSIT model can be used to guide healthcare practitioners in assessing and addressing the needs of this group of patients. The man’s partner should be included in assessment and interventions where appropriate.

Nursing Standard. 30, 12, 38-44. doi: 10.7748/ns.30.12.38.s46



Peer review

All articles are subject to external double-blind peer review and checked for plagiarism using automated software.

Received: 06 February 2015

Accepted: 07 May 2015

Want to read more?

Subscribe for unlimited access

Try 1 month’s access for just £1 and get:

Your subscription package includes:
  • Full access to nursingstandard.com and the Nursing Standard app
  • The monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal
Already subscribed? Log in

Alternatively, you can purchase access to this article for the next seven days. Buy now